1-3 of 3
Evgeny Mikler
Close
Sort by
Journal Articles

Obatoclax in Combination with Fludarabine and Rituximab (FR) Is Well-Tolerated and Shows Promising Clinical Activity in Relapsed CLL/SLL

Jennifer R Brown, MD, PhD, Bethany Tesar, Lillian Werner, Evgeny Mikler, Hazel Reynolds, Christina Thompson, David C. Fisher, MD, Naoko Takebe, MD, PhD, Donna Neuberg, ScD, Arnold S. Freedman, MD
Journal: Blood
Blood (2011) 118 (21): 2865.
https://doi.org/10.1182/blood.V118.21.2865.2865
Published: 2011
Journal Articles

A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab In Relapsed CLL/SLL.

Jennifer R Brown, MD, PhD, Bradley Messmer, Lillian Werner, Evgeny Mikler, David C. Fisher, MD, Ann LaCasce, MD, MSc, Philippe Armand, MD, PhD, Eric D Jacobsen, MD, Virginia Dalton, Bethany Tesar, Stacey M Fernandes, Sean McDonough, MS, Jerome Ritz, MD, Laura Z Rassenti, PhD, Thomas J. Kipps, MD, PhD, Donna Neuberg, ScD, Arnold S. Freedman, MD
Journal: Blood
Blood (2010) 116 (21): 1381.
https://doi.org/10.1182/blood.V116.21.1381.1381
Published: 2010
Journal Articles

A Phase I Study of Lenalidomide in Combination with Fludarabine-Rituximab in Previously Untreated CLL/SLL.

Jennifer R Brown, MD, PhD, Jeremy S. Abramson, MD, Ephraim P. Hochberg, MD, Evgeny Mikler, Virginia Dalton, Hazel Reynolds, Jennifer Romano, Lillian Werner, MS, Christina Thompson, Sean McDonough, Jerome Ritz, MD, Donna Neuberg, ScD, Arnold S. Freedman, MD
Journal: Blood
Blood (2009) 114 (22): 3426.
https://doi.org/10.1182/blood.V114.22.3426.3426
Published: 2009